The present, updated document describes the fourth iteration of recommendations for the
hepatic use of contrast enhanced ultrasound (CEUS), first initiated in 2004 by the European …

Initially, a set of guidelines for the use of ultrasound contrast agents was published in 2004
dealing only with liver applications. A second edition of the guidelines in 2008 reflected …

The first studies on the clinical use of ultrasound contrast agents (UCAs) with contrast
specific imaging techniques were published at the beginning of this century using Levovist® …

Thieme E-Journals - Ultraschall in der Medizin - European Journal of Ultrasound / Full Text DE
EN Home Products Journals Books Book Series Service Library Service Help Contact Portal …

The first edition of the guidelines for the use of ultrasound contrast agents was published in
2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected …

The introduction of second-generation microbubble ultrasound contrast agents and the
development of contrast specific ultrasound techniques have improved the ability of contrast …

The development of ultrasound contrast agents (UCAs), which perform as blood pool
tracers, have overcome the limitations of conventional B-Mode and colour or power Doppler …

Objectives To assess the respective diagnostic value of Sonazoid™ and SonoVue® for
characterizing FLLs as benign or malignant and the corresponding safety. Methods This …

Contrast-enhanced ultrasound (CEUS) has become an established modality in various
clinical indications for liver diseases. SonoVue®, a pure blood pure agent, and Sonazoid® …

The use of contrast-enhanced ultrasound (CEUS) in adults is well established in many
different areas, with a number of current applications deemed “off-label”, but the use …